Lundgren S, Moy P K, Beumer J, Lewis S
Orofacial Implant Center, UCLA Medical Center 90024.
Int J Oral Maxillofac Surg. 1993 Oct;22(5):272-7. doi: 10.1016/s0901-5027(05)80514-4.
From 1987 to 1990, 28 patients were treated with titanium implants (Brånemark flange fixtures) in the craniofacial area for the support of craniofacial prosthesis or anchorage of bone-conduction hearing aids in the Orofacial Implant Center at the University of California, Los Angeles (UCLA). A total of 88 implants were placed, of which 22 were placed in previously irradiated areas. Twenty-three of the implants were placed in the orbital area, 37 in the mastoid area, 20 in the nasal area, and eight in various other craniofacial regions. Seven implants were lost in four different patients. The proper location and positioning of implants in specific areas of the craniofacial regions, as well as soft-tissue complications and management, are discussed.
1987年至1990年期间,28例患者在加利福尼亚大学洛杉矶分校(UCLA)口腔颌面种植中心接受了钛种植体(Brånemark法兰固定装置)治疗,用于支持颅面假体或固定骨传导助听器。共植入88枚种植体,其中22枚植入先前接受过放射治疗的区域。23枚种植体植入眼眶区域,37枚植入乳突区域,20枚植入鼻腔区域,8枚植入其他不同的颅面区域。4例不同患者的7枚种植体出现松动。本文讨论了种植体在颅面区域特定部位的正确位置和植入方式,以及软组织并发症和处理方法。